R1 RCM is a health information services business based in the US. R1 RCM shares (RCM) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $56.00 – a decrease of 3.45% over the previous week. R1 RCM employs 29,400 staff and has a trailing 12-month revenue of around $2.5 billion.
Offer ends 4/1/25. Customer must fund their Active invest account with at least $50 within 30 days of opening the account. Probability of customer receiving $2,000 is 0.028%. See full terms and conditions at https://www.sofi.com/greenintwoterms/.
Open an account.Provide your personal information and sign up.
Fund your account.Deposit funds into your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – RCM.Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.
Buy R1 RCM stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
R1 RCM stock price (NASDAQ: RCM)
Use our graph to track the performance of RCM stocks over time.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
R1 RCM price performance over time
Historical closes compared with the close of $56 from 2025-01-09
1 week (2025-03-11)
N/A
1 month (2025-02-18)
N/A
3 months (2024-12-20)
33.33%
6 months (2024-09-20)
295.48%
1 year (2024-03-22)
330.77%
2 years (2023-03-22)
306.98%
3 years (2022-03-22)
118.32%
5 years (2020-03-20)
532.77%
Is R1 RCM stock undervalued or overvalued?
Valuing R1 RCM stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of R1 RCM's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
R1 RCM's PEG ratio
R1 RCM's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0582. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into R1 RCM's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
R1 RCM's EBITDA
R1 RCM's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $518.4 million.
The EBITDA is a measure of a R1 RCM's overall financial performance and is widely used to measure a its profitability.
R1 RCM financials
Revenue TTM
$2.5 billion
Operating margin TTM
3.78%
Gross profit TTM
$472.7 million
Return on assets TTM
2.35%
Return on equity TTM
-2.2%
Profit margin
-2.48%
Book value
$6.66
Market Capitalization
$6 billion
TTM: trailing 12 months
R1 RCM share dividends
We're not expecting R1 RCM to pay a dividend over the next 12 months.
Have R1 RCM's shares ever split?
R1 RCM's shares were
split on 21 June 2022
.
R1 RCM share price volatility
Over the last 12 months, R1 RCM's shares have ranged in value from as little as $10.575 up to $14.32. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while R1 RCM's is 0.842. This would suggest that R1 RCM's shares are less volatile than average (for this exchange).
R1 RCM overview
R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. R1 RCM Inc. was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc.
Frequently asked questions
What percentage of R1 RCM is owned by insiders or institutions? Currently 1.044% of R1 RCM shares are held by insiders and 86.914% by institutions.How many people work for R1 RCM? Latest data suggests 29,400 work at R1 RCM.When does the fiscal year end for R1 RCM? R1 RCM's fiscal year ends in December.Where is R1 RCM based? R1 RCM's address is: 434 W. Ascension Way, Murray, UT, United States, 84123What is R1 RCM's ISIN number? R1 RCM's international securities identification number is: US7493971052What is R1 RCM's CUSIP number? R1 RCM's Committee on Uniform Securities Identification Procedures number is: 00438V103
A deep dive into the highlights and limitations of Robinhood.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
